Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
J Periodontol ; 69(10): 1164-6, 1998 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-9802717

RESUMO

Gingival salivary gland choristoma is an extremely rare disturbance of glandular development. A review of the literature disclosed only 5 reported cases of this entity and 7 gingival salivary gland tumors or alterations. We present a case of this condition present in a 43-year-old female patient, which was found while reviewing casts for the design of a prosthetic appliance. This case suggests that embryonal pluripotentiality of gingival epithelial cells is retained and that development of salivary glands in gingival tissue is feasible. An additional discussion about its histogenesis is presented.


Assuntos
Coristoma/patologia , Doenças da Gengiva/patologia , Glândulas Salivares Menores , Adulto , Diagnóstico Diferencial , Células Epiteliais/patologia , Feminino , Fibroma/patologia , Gengiva/patologia , Neoplasias Gengivais/patologia , Humanos , Glândulas Salivares Menores/patologia , Células-Tronco/patologia
2.
Artigo em Inglês | MEDLINE | ID: mdl-9431538

RESUMO

Reports about the frequency of odontogenic tumors are scarce, and diagnostic criteria used in the reports are not uniform. This article presents the results of a retrospective study of odontogenic tumors recorded in four services of diagnostic pathology in Mexico City (two dental schools, one cancer hospital, and one private oral pathology service). The final diagnosis in each case was based on the 1992 histologic criteria of the World Health Organization. The frequency of odontogenic tumors, expressed as a percent of all oral and maxillofacial specimens, ranged from 0.8% in the cancer hospital (0.02% of all biopsies) to 3.7% in the private oral pathology service. The frequency was identical for the two dental schools (2.5%). We found a total of 349 odontogenic tumors; of these, 345 were benign (98.8%), and 4 (1.1%) were malignant (3 were primary intraosseous carcinomas and 1 was a malignant ameloblastoma). The most frequently occurring tumors were odontoma (34.6%), ameloblastoma (23.7%), myxoma (17.7%), adenomatoid odontogenic tumor (7.1%), and calcifying odontogenic cyst (6.8%). Although relatively rare, odontogenic tumors are still an important cause of extensive surgical procedures in Mexico.


Assuntos
Neoplasias Maxilomandibulares/epidemiologia , Tumores Odontogênicos/epidemiologia , Adolescente , Adulto , Idoso , Ameloblastoma/epidemiologia , Institutos de Câncer , Criança , Pré-Escolar , Feminino , Humanos , Neoplasias Maxilomandibulares/diagnóstico , Neoplasias Maxilomandibulares/patologia , Neoplasias Maxilomandibulares/cirurgia , Laboratórios , Masculino , México/epidemiologia , Pessoa de Meia-Idade , Cisto Odontogênico Calcificante/epidemiologia , Tumores Odontogênicos/diagnóstico , Tumores Odontogênicos/patologia , Tumores Odontogênicos/cirurgia , Odontoma/epidemiologia , Patologia Bucal , Estudos Retrospectivos , Faculdades de Odontologia , Organização Mundial da Saúde
3.
Bol Estud Med Biol ; 44(1-4): 25-30, 1996.
Artigo em Inglês | MEDLINE | ID: mdl-9369034

RESUMO

Several forms of cell perturbation have been associated with ethanol ingestion. Fetal alcohol syndrome (FAS) as well as diminished maxillofacial development and inhibition of cell regeneration in vitro and in vivo have been described. Epidermal growth factor (EGF) stimulates maxillofacial growth, DNA synthesis, and it is a potent mitogen for a number of various cell types. EGF exerts its effects on cells through binding to a specific cell surface receptor which leads to activation of a thyrosine kinase in the intracellular part of the receptor. The inhibitory effect of alcohol on EGF in the mouse dental follicle was studied in the offspring of alcoholic mothers using immunocytochemistry. Adult female mice were given 22% alcohol in their drinking water and fed a pelleted diet before and during pregnancy. Maternal blood alcohol levels were 262 +/- 1.3 mg/100 ml on gestation day 12.5. The offspring of the alcoholic and control mice were sacrificed on postnatal day 1.5, their mandibles were dissected, weighed and processed by routine immunocytochemistry with the following results. 1) Significant differences were found in mandible weight p < 0.01 after parturition. 2) The tooth germs in the offspring of ethanol treated mice were morphometrically smaller than those of control littermates. 3) Immunoexpression of EGF in the mandibular first molar of the control group was strong and homogeneous while in the experimental group the expression was light and heterogeneous. It is concluded that maternal alcoholism reduces EGF in the offspring.


Assuntos
Fator de Crescimento Epidérmico/metabolismo , Transtornos do Espectro Alcoólico Fetal/metabolismo , Mandíbula/metabolismo , Odontogênese , Animais , Peso Corporal , Feminino , Imuno-Histoquímica , Masculino , Camundongos , Gravidez
4.
Rev. Inst. Nac. Cancerol. (Méx.) ; 41(2): 93-6, abr.-jun. 1995.
Artigo em Espanhol | LILACS | ID: lil-161934

RESUMO

Recientemente, se ha demostrado que la manifestación de inmunidad antitumoral resulta de las interacciones entre varias poblaciones celulares del sistema inmune. La inmunoterapia con interleucina-2 (IL-2) y células destructoras de linfocinas activadas generadas por linfocitos análogos ha producido regresiones significativas en tumore de pacientes con cáncer avanzado. El efecto mitogénico de la IL-2 en linfocitos T citolíticos de tumores-reactivos (CTL), destructores naturales y LAK puede incrementar el potencial de defensa en la expansión de tumores. A diferencia del tratamiento sistémico, la administración de IL-2 en la vecindad del tumor puede ofrecer ciertas ventajas, tales como: uso de dosis bajas y menos anticuerpos anti IL-2 y proveer un cambio de confrontación mucho mejor con inhibidores IL-2 y mecanismos de retroalimentación, los cuales podrán limitar sustancialmente los posibles efectos terapéuticos de la IL-2 en pacientes con tumores


Assuntos
Camundongos , Humanos , Animais , Adenocarcinoma/terapia , Técnicas In Vitro , Interleucina-2/fisiologia , Interleucina-2/uso terapêutico , Interleucina-2/toxicidade , Neoplasias Renais/terapia , Linfoma/terapia , Neoplasias da Próstata/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA